2nd June to 3rd June 2023
Singapore Hepatology
Conference 2023
8:30 am to 5:00 pm (SGT)
SHC 2023
REGISTRATION FOR The Inaugural Combined GIHep & Singapore Hepatology Conference includes SHC 2023!
We remain committed to delivering Short, Focused Clinical Updates on all aspects of Hepatology from the World’s leading experts.
SHC 2023 Scientific Programme
June, 2023
2
|
Programme
|
Time (SGT)
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Welcome Remarks by the Conference Chairpersons | 08:15 – 8:30 | ||||||||||||||
| CHB Therapy 1 Chairs: Prof. Ed Gane, Prof. Rino Gani, |
|||||||||||||||
| Challenges for CHB functional cure – Prof. Geoffrey Dusheiko View Bio |
08:30 – 08:45 | ||||||||||||||
| Endpoints for CHB Therapy – Prof. Markus Cornberg View Bio |
08:45 – 09:00 | ||||||||||||||
| CHB Therapy 2 Chairs: Dr. Rajneesh Kumar, Prof. Pietro Lampertico, Dr. Soek Siam Tan |
|||||||||||||||
| Consolidating guidelines for CHB (Pre-recording) – Prof. Teerha Piratvisuth View Bio |
09:00 – 09:15 | ||||||||||||||
| New China guidelines for CHB (Pre-recording) – Prof. Jidong Jia View Bio |
09:15 – 09:30 | ||||||||||||||
| Expanding treatment groups for CHB – Prof. Henry Chan View Bio |
09:30 – 09:45 | ||||||||||||||
| CHB Therapy 1 and CHB Therapy 2 Combined Round table discussion | 09:45 – 10:00 | ||||||||||||||
| Roche Morning Tea Symposium Expanding Horizons in HCC: Early Detection and Systemic Treatment Opportunities (View Details)
|
10:00 – 10:45 | ||||||||||||||
| CHB Therapy 3 Chairs: Prof. MF Yuen, Dr. Yang Wei Lyn, Dr. Rinaldi Lesmana |
|||||||||||||||
| Landscape of CHB cure therapies – Prof. Man Fung Yuen View Bio |
10:45 – 11:00 | ||||||||||||||
| Challenges in CHB management: stop or continue NA therapy? – Prof. Markus Cornberg View Bio |
11:00 – 11:15 | ||||||||||||||
| HDV in cirrhosis: Best management practices – Prof. Pietro Lampertico View Bio |
11:15 – 11:30 | ||||||||||||||
| Round table discussion | 11:30 – 11:45 | ||||||||||||||
| Case Discussion:A case of Delta and HBV co-infection – Presenter: Dr. Zain Majid, Sindh Institute, Pakistan |
11:45 – 12:00 | ||||||||||||||
| Astra Zeneca Lunch Symposium Recent Advancements in HCC & BTC: What Hepatologists and Gastroenterologists Should Know? (View Details)
|
12:00 – 13:30 | ||||||||||||||
| HCC Symposium Part 1 Chairs: Prof. Yock Young Dan (Singapore), Dr. George Goh (Singapore) |
|||||||||||||||
| Risk stratification for HCC risk – Prof. Henry Chan View Bio |
13:30 – 13:45 | ||||||||||||||
| Emerging biomarkers for HCC screening – Prof. Simone Strasser View Bio |
13:45 – 14:00 | ||||||||||||||
| Spectrum of therapies for locoregional therapy (Pre-Recorded) – Prof. Masatoshi Kudo View Bio |
14:00 – 14:15 | ||||||||||||||
| Debate: Personalised therapy for small HCC: are we there yet? – YES Prof. Pierce Chow View Bio – NO Prof. Alfred Kow View Bio |
14:15 – 14:35 | ||||||||||||||
| Case discussion:Resection of Large HCC – Presenter: Dr. Gillie Anne D. Domingo, Makati Medical Center, Manila, Philippines |
14:35 – 14:45 | ||||||||||||||
| Free paper: Assessment of GALAD score for surveillance of hepatocellular carcinoma in Singapore – Dr Liou Wei Lun, Dept of Gastroenterology and Hepatology, Singapore General Hospital |
14:45 – 15:00 | ||||||||||||||
| Q&A | 15:00 – 15:15 | ||||||||||||||
| Round Table Discussion | 15:15 – 15:30 | ||||||||||||||
| Tea Break | 15:30 – 15:45 | ||||||||||||||
| HCC Symposium Part 2 Chairs: Prof. Shadab Siddique & Dr. Mark Muthiah |
|||||||||||||||
| Immunotherapy as adjuvant therapy after resection or ablation – Prof. Pierce Chow View Bio |
15:45 – 16:00 | ||||||||||||||
| Intermediate HCC: challenges in management (Pre-recorded) – Dr Raghav Sundar View Bio |
16:00– 16:15 | ||||||||||||||
| Rescue Therapy for advanced HCC – Prof. Han Chong Toh View Bio |
16:15 – 16.30 | ||||||||||||||
| Advances in systemic therapy? – Dr Chee Cheng Ean View Bio |
16:30– 16:45 | ||||||||||||||
| Case discussion – HCC infiltrated Portal Vein and Inferior Vena Cava – Dr Ahmad Yusran, MD, Hepatology Division, Department of Internal Medicine, Cipto Mangunkusumo General Hospital-Faculty of Medicine Universitas Indonesia, Indonesia |
16:45 – 17:00 | ||||||||||||||
| Round table discussion | 17:00 – 17:15 | ||||||||||||||
| Liver Disease in South East Asia Forum –
Chairs: Prof. Chan Wah Kheong, Dr. Tan Poh Seng, A/Prof, Jason Chang, Panelists: Prof. Rino Gani, Dr. Soek Siam Tan, Dr. Khin Maung Win, Dr. Lee Guan Huei, Prof. Teerha Piratvisuth (8 mins each) Discussion |
17:15 – 18:00 | ||||||||||||||
June, 2023
3
| Programme | Time (SGT) |
|---|---|
| NASH Chairs: Prof. Yock Young Dan, Prof. Arun Sanyal, Dr. George Goh |
|
| Management of the NASH patient today – Prof. Vincent Wong View Bio |
08:30 – 08:45 |
| Pitfalls in histology interpretation in NASH? – Prof. Arun Sanyal View Bio |
08:45 – 09:00 |
| Optimising diet interventions for NASH – Prof. Chan Wah Kheong View Bio |
09:00 – 09:15 |
| Debate: NASH treatment– is all about weight loss – YES Prof. Shadab Siddiqui View Bio – NO Prof. Vincent Wong View Bio |
09:15 – 09:35 |
| End organ complications of NASH – Prof. Shadab Siddiqui View Bio |
09:35 – 09:50 |
| Free paper: Comparative efficacy of Fibrosis-4, liver stiffness measurement, and Fibroscan-AST score to predict major liver-related outcomes in non-alcoholic fatty liver disease: An international multicenter study – Dr. Yu Jun WONG, Singapore View Bio |
09:50 – 10:00 |
| Round table discussion | 10:00 – 10:15 |
| Morning Tea Symposium | 10:15 – 10:45 |
| Hot Topics in Hepatology Chairs: Prof. Vincent Wong, Prof. Khin Maung Win |
|
| Microbiome and Fatty Liver: the gut actually matters? – Dr. Jonathan Lee View Bio |
10:45 – 11:00 |
| HCV update: improving access to care – Dr. Soek Siam Tan View Bio |
11:00 – 11:15 |
| Immune checkpoint inhibitor hepatitis – Dr. Mark Muthiah View Bio |
11:15 – 11:30 |
| Case Discussion: Diagnostic Uncertainty in Autoimmune Liver Disease – Presenter: Dr. Darlene Raudhatul Bahri, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
11:30- 11:45 |
| Q&A | 11:45- 12:00 |
| Lunch Symposium | 12:00 – 13:30 |
| Advanced Liver Disease Chairs: Prof. Simone Strasser , Dr. Soek Siam Tan, Prof. Jason Chang |
|
| Window of opportunity for beta blockers in portal hypertension – Prof. Guadalupe Garcia-Tsao View Bio |
13:30 – 13:45 |
| Peri-operative management of the cirrhotic patient – Prof. Simone Strasser View Bio |
13:45 – 14:00 |
| Transplantation for ALF/ACLF – Prof. Ajay Duseja View Bio |
14:00 – 14:15 |
| Debate: Direct Oral Anti-Coagulation (DOAC) are appropriate in portal vein thrombosis – YES Prof. Guadalupe Garcia-Tsao View Bio – NO Prof. Rajender Reddy View Bio |
14:15 – 14:35 |
| Case discussion: Ascites in an adolescent –Presenter: Dr Arjun Maria Sir Ganga Ram Hospital, New Delhi, India |
14:35 – 14:50 |
| Round Table Discussion | 14:50 – 15:05 |
| Tea Break | 15:05 – 15:30 |
| Liver Transplantation Chairs: Prof. Rajender Reddy , Dr. Mark Muthiah, Prof. Ajay Duseja |
|
| Can immunosuppression be stopped post liver transplant – Prof. Simone Strasser View Bio |
15:30 – 15:45 |
| Downstaging HCC for liver transplant – Prof. Shridhar Iyer View Bio |
15:45– 16:00 |
| Onco transplant: the new frontier – Prof. Glenn Bonney View Bio |
16:00 – 16:15 |
| Viewpoint: Liver transplant in the East versus the West – West Prof. Shadab Siddiqui View Bio – East Dr. Alfred Kow View Bio |
16:15– 16:35 |
| Case discussion – Downstaging BCLC HCC – can transplant be considered? – Presenter: Dr Dinu Abirami P, Gleneagles Global Health City, Chennai, India. |
16:35 – 16:50 |
| Round table discussion | 16:50 – 17:05 |
| Closing Comments | 17:05 – 17:15 |
Who Should Attend?
SHC 2023 is designed for clinicians, scientists nurse practitioners, pharmacists, from Asia, Australia and New Zealand, to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.
Our Attendees Include:
- Hepatology experts.
- Clinical, basic, and translational researchers.
- Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
- Primary care physicians.
- Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
- Trainees, and students in the disciplines listed above.
Call for Abstracts
We invite all interested parties to present their research papers. Click bellow on Abstracts and Posters for further information.
Abstracts will be reviewed by the Abstract Selection Committee and accepted submissions will be posted on Abstract & Poster Gallery in our website and in the Poster Hall.
Some travel grants will be available to selected Presenters.